Reuters logo
BRIEF-Arca Biopharma announces 200th patient randomized into the genetic-AF phase 2b/3 clinical trial
April 26, 2017 / 12:37 PM / 5 months ago

BRIEF-Arca Biopharma announces 200th patient randomized into the genetic-AF phase 2b/3 clinical trial

April 26 (Reuters) - Arca Biopharma Inc

* Arca Biopharma announces 200th patient randomized into the genetic-AF seamless design phase 2b/3 clinical trial

* Outcome of phase 2B interim efficacy analysis anticipated in September 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below